Title |
Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects
|
---|---|
Published in |
Brazilian Journal of Medical and Biological Research, February 2001
|
DOI | 10.1590/s0100-879x2001000200004 |
Pubmed ID | |
Authors |
A.C. Sposito, A.P. Mansur, R.C. Maranhão, C.R.M. Rodrigues-Sobrinho, O.R. Coelho, J.A.F. Ramires |
Abstract |
Etofibrate is a hybrid drug which combines niacin with clofibrate. After contact with plasma hydrolases, both constituents are gradually released in a controlled-release manner. In this study, we compared the effects of etofibrate and controlled-release niacin on lipid profile and plasma lipoprotein (a) (Lp(a)) levels of patients with triglyceride levels of 200 to 400 mg/dl, total cholesterol above 240 mg/dl and Lp(a) above 40 mg/dl. These patients were randomly assigned to a double-blind 16-week treatment period with etofibrate (500 mg twice daily, N = 14) or niacin (500 mg twice daily, N = 11). In both treatment groups total cholesterol, VLDL cholesterol and triglycerides were equally reduced and high-density lipoprotein cholesterol was increased. Etofibrate, but not niacin, reduced Lp(a) by 26% and low-density lipoprotein (LDL) cholesterol by 23%. The hybrid compound etofibrate produced a more effective reduction in plasma LDL cholesterol and Lp(a) levels than controlled-release niacin in type IIb dyslipidemic subjects. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 23 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 17% |
Professor | 4 | 17% |
Student > Bachelor | 4 | 17% |
Student > Ph. D. Student | 2 | 9% |
Student > Doctoral Student | 1 | 4% |
Other | 4 | 17% |
Unknown | 4 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 43% |
Chemistry | 3 | 13% |
Agricultural and Biological Sciences | 3 | 13% |
Biochemistry, Genetics and Molecular Biology | 2 | 9% |
Nursing and Health Professions | 1 | 4% |
Other | 0 | 0% |
Unknown | 4 | 17% |